1. Barbalho SM, Flato UAP, Tofano RJ, et al. Physical exercise and myokines: relationships with sarcopenia and cardiovascular complications. Int J Mol Sci. 2020;21(10):3607. doi:10.3390/ijms21103607
2. Qi C, Song X, Wang H, Yan Y, Liu B. The role of exercise-induced myokines in promoting angiogenesis. Front Physiol. 2022;13:981577. doi:10.3389/fphys.2022.981577
3. Severinsen MCK, Pedersen BK. Muscle–organ crosstalk: the emerging roles of myokines. Endocr Rev. 2020;41(4):594-609. doi:10.1210/endrev/bnaa016
4. Iglesias P. Muscle in endocrinology: from skeletal muscle hormone regulation to myokine secretion and its implications in endocrine-metabolic diseases. J Clin Med. 2025;14(13):4490. doi:10.3390/jcm1413 4490
5. Zhu M, Chen W, Zhang J. Aerobic exercise, an effective intervention for cognitive impairment after ischemic stroke. Front Aging Neurosci. 2025; 17:1514271. doi:10.3389/fnagi.2025.1514271
6. De Assis GG, Murawska-Cialowicz E. Brain-derived neurotrophic factor and stroke: perspectives on exercise as a health care strategy. Hum Mov. 2024;25(1):1-14. doi:10.5114/hm.2024.136050
7. Jodeiri Farshbaf M, Alviña K. Multiple roles in neuroprotection for the exercise-derived myokine irisin. Front Aging Neurosci. 2021;13:649929. doi:10.3389/fnagi.2021.649929
8. Villamil-Parra W, Moscoso-Loaiza L. Effects of physical exercise on irisin and BDNF concentrations, and their relationship with cardiometabolic and mental health of individuals with metabolic syndrome: a systematic review. Exp Gerontol. 2024;198:112640. doi:10.1016/j.exger.2024.112640
9. Montero-Almagro G, Bernal-Utrera C, Geribaldi-Doldán N, Nunez-Abades P, Castro C, Rodriguez-Blanco C. Influence of high-intensity interval training on neuroplasticity markers in post-stroke patients: systematic review. J Clin Med. 2024;13(7):1985. doi:10.3390/jcm13071985
10. Grzeskiewicz M, Kobak JE, Drewniak H, Terlecki P, Przywara S. Irisin-the future of ischemic stroke therapy? Acta Angiol. 2023;29(1):19-24. doi:10.5603/AA.2023.0006
11. Xiao W, Yang Y, Bai L, et al. Exercise-induced irisin ameliorates cognitive impairment following chronic cerebral hypoperfusion by suppressing neuroinflammation and hippocampal neuronal apoptosis. J Neuroinflammation. 2025;22(1):168. doi:10.1186/s12974-025-03493-5
12. Chen X, Zhang G, Liu M, He J, Zhang Z. New perspectives on molecular mechanisms underlying exercise-induced benefits in Parkinson disease. NPJ Parkinsons Dis. 2025;11(1):256. doi:10.1038/s41531-025-01113-w
13. Yani S, Harris S, Jusuf AA, Goenarjo R, Makkiyah FA, Sabita R, Ibrahim N. Effect of high-intensity interval training on BDNF level in ischemic stroke rat model on recovery of motor function. Indones Biomed J. 2024; 16(2):152-161.
14. Puoyan-Majd S, Parnow A, Rashno M, Heidarimoghadam R, Komaki A. Effects of pretreatment with coenzyme Q10 and high-intensity interval training on FNDC5, irisin, and BDNF levels and amyloid-beta plaque formation in hippocampus of Aß-induced Alzheimer disease rats. CNS Neurosci Ther. 2025;31(2):e70221. doi:10.1111/cns.70221
15. Skrypnik D, Skrypnik K, Granell JC, Woszczyk D, Suliburska J. Cardiac rehabilitation influences serum myokine levels in patients after acute coronary syndrome: the randomised CARDIO-REH study. Sci Rep. 2025;15(1):38951. doi:10.1038/s41598-025-22897-0
16. Damay VA, Setiawan S, Lesmana R, Akbar MR, Lukito AA. Effects of moderate-intensity aerobic exercise on FSTL-1 regulation in atherosclerosis: a systematic review. Int J Angiol. 2023;32(1):1-10. doi:10. 1055/s-0042-1750184
17. Esmaeili M, Vettukattil R. Exercise intensity and cardiac metabolic adaptations in elderly heart failure rehabilitation: a review. Int J Cardiol Cardiovasc Risk Prev. 2025;27:200525. doi:10.1016/j.ijcrp.2025.200525
18. Yang M, Liu C, Jiang N, et al. Myostatin: a potential therapeutic target for metabolic syndrome. Front Endocrinol (Lausanne). 2023;14:1181913. doi:10.3389/fendo.2023.1181913
19. Lenk K, Erbs S, Höllriegel R, et al. Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure. Eur J Prev Cardiol. 2012;19(3):404-411. doi:10.1177/1741826711402735
20. Ramirez-Velez R, Gonzalez A, Garcia-Hermoso A, Amezqueta IL, Izquierdo M, Diez J. Revisiting skeletal myopathy and exercise training in heart failure: emerging role of myokines. Metabolism. 2023;138: 155348. doi:10.1016/j.metabol.2022.155348
21. Lyu JX, Guo DD, Song YC, et al. Circulating myokines as novel biomarkers for cardiovascular diseases. Rev Cardiovasc Med. 2024;25(2): 56.
22. Minko A, Turon-Skrzypinska A, Ryl A, Mankowska K, Cymbaluk-Ploska A, Rotter I. The significance of selected myokines in predicting the length of rehabilitation of patients after COVID-19 infection. Biomedicines. 2024;12(4):836. doi:10.3390/biomedicines12040836
23. Luo C, Li L, Hou L, Shi F. Effects of tiered cardiac rehabilitation on CRP, TNF-?, and physical endurance in older adults with coronary heart disease. Open Life Sci. 2025;20(1):20221040.
24. Pedersen BK, Fischer CP. Beneficial health effects of exercise-the role of IL-6 as a myokine. Trends Pharmacol Sci. 2007;28(4):152-156. doi:10. 1016/j.tips.2007.02.002
25. Tero-Vescan A, Degens H, Matsakas A, et al. Exercise-induced muscle-fat crosstalk: molecular mediators and their pharmacological modulation for the maintenance of metabolic flexibility in aging. Pharmaceuticals (Basel). 2025;18(8):1222. doi:10.3390/ph18081222
26. Leal LG, Lopes MA, Batista ML Jr. Physical exercise-induced myokines and muscle-adipose tissue crosstalk: a review of current knowledge and the implications for health and metabolic diseases. Front Physiol. 2018;9: 1307. doi:10.3389/fphys.2018.01307
27. Shakoor H, Kizhakkayil J, Statsenko Y, Platat C. Separate and combined effects of moderate-intensity exercise training and detraining with protocatechuic acid on myokines and insulin-signaling pathways in male Wistar rats: a preclinical randomized study. Metabolites. 2025; 15(2):87. doi:10.3390/metabo15020087
28. Rodríguez A, Becerril S, Ezquerro S, Méndez-Giménez L, Frühbeck G. Crosstalk between adipokines and myokines in fat browning. Acta Physiol (Oxf). 2017;219(2):362-381. doi:10.1111/apha.12686
29. Villamil-Parra W, Moscoso-Loaiza L. Effects of physical exercise on irisin and BDNF in metabolic syndrome. Exp Gerontol. 2024;198:112640. doi:10.1016/j.exger.2024.112640
30. Sanchis-Gomar F, Perez-Quilis C. The p38-PGC-1?-irisin-betatrophin axis: exploring new pathways in insulin resistance. Adipocyte. 2014;3(1): 67-68. doi:10.4161/adip.26709
31. Kour H, Sharma H. Exercise-induced myokines: molecular mechanisms and systemic health benefits. Indian J Clin Anat Physiol. 2025;12(3):101-106.
32. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997;387:83-90. doi:10.1038/387083a0
33. Baig MH, Ahmad K, Moon JS, et al. Myostatin and its regulation: a comprehensive review of myostatin inhibiting strategies. Front Physiol. 2022;13:876078. doi:10.3389/fphys.2022.876078
34. Rodgers BD, Ward CW. Myostatin/activin receptor ligands in muscle and the development status of attenuating drugs. Endocr Rev. 2022;43(2): 329-365. doi:10.1210/endrev/bnab030
35. Stefanetti RJ, Voisin S, Russell A, Lamon S. Recent advances in understanding the role of FOXO3. F1000Res. 2018;7:F1000 Faculty Rev-1372. doi:10.12688/f1000research.15258.1
36. Braun T, Gautel M. Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat Rev Mol Cell Biol. 2011;12(6):349-361. doi:10.1038/nrm3118
37. George I, Bish LT, Kamalakkannan G, et al. Myostatin activation in patients with advanced heart failure and after mechanical unloading. Eur J Heart Fail. 2010;12(5):444-453. doi:10.1093/eurjhf/hfq039
38. Siff T, Parajuli P, Razzaque MS, Atfi A. Cancer-mediated muscle cachexia: etiology and clinical management. Trends Endocrinol Metab. 2021;32(6):382-402. doi:10.1016/j.tem.2021.03.007
39. Heineke J, Auger-Messier M, Xu J, et al. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation. 2010;121(3):419-425. doi:10.1161/CIRCULATIONAHA.109.882068
40. Han HQ, Zhou X, Mitch WE, Goldberg AL. Myostatin/activin pathway antagonism: molecular basis and therapeutic potential. Int J Biochem Cell Biol. 2013;45(10):2333-2347. doi:10.1016/j.biocel.2013.05.019
41. McPherron AC. The ups and downs of exercise and insulin sensitivity: a role for the myokine myostatin in glucose metabolism? Acta Physiol (Oxf). 2016;217(1):6-10. doi:10.1111/apha.12635
42. Chung HS, Choi KM. Exercise, exerkines, and sarcopenia. Diabetes Metab J. 2026;50(1):19.
43. Quinn LS, Anderson BG, Strait-Bodey L, Stroud AM, Argilés JM. Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab. 2009;296(1):E191-E202. doi:10.1152/ajpendo.90506.2008
44. Kharitonenkov A, Wroblewski VJ, Koester A, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology. 2007;148(2):774-781. doi:10.1210/en.2006-1168
45. Schlein C, Talukdar S, Heine M, et al. FGF21 lowers plasma triglycerides by accelerating lipoprotein catabolism in white and brown adipose tissues. Cell Metab. 2016;23(3):441-453. doi:10.1016/j.cmet.2016.01.006
46. Dutchak PA, Katafuchi T, Bookout AL, et al. Fibroblast growth factor-21 regulates PPAR? activity and the antidiabetic actions of thiazolidinediones. Cell. 2012;148(3):556-567. doi:10.1016/j.cell.2011.11. 062
47. Schreuder TC, Marsman HA, Lenicek M, et al. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. Am J Physiol Gastrointest Liver Physiol. 2010;298(3):G440-G445. doi:10.1152/ajpgi.00322.2009
48. Yu Y, Chen K. Peripheral immune and metabolic regulation of Aß and Tau by exercise in Alzheimer’s disease. Front Immunol. 2025;16:1678526. doi:10.3389/fimmu.2025.1678526
49. Szucs G, Pipicz M, Szabó MR, Csont T, Török L, Csonka C. Effect of eccentric exercise on metabolic health in diabetes and obesity. Sports Med Open. 2023;9(1):91. doi:10.1186/s40798-023-00636-7
50. Feng J, Wang X, Lu Y, Yu C, Wang X, Feng L. BAIBA involves in hypoxic training-induced browning of white adipose tissue in obese rats. Front Physiol. 2022;13:882151. doi:10.3389/fphys.2022.882151
51. Jung TW, Hwang HJ, Hong HC, Yoo HJ, Baik SH, Choi KM. BAIBA attenuates insulin resistance and inflammation induced by palmitate or a high-fat diet via an AMPK-PPAR?-dependent pathway in mice. Diabetologia. 2015;58(9):2096-2105. doi:10.1007/s00125-015-3663-z
52. Rouholamini FS, Aminaei M, Aminizadeh S. Effect of eight weeks of endurance training and MitoQ supplementation on antioxidant capacity and the expression of sestrin-2 and AMPK in cardiac tissue of aged rats. Exp Gerontol. 2024;196:112572. doi:10.1016/j.exger.2024.112572
53. Seo K, Ki SH, Shin SM. Sestrin2-AMPK activation protects mitochondrial function against glucose deprivation-induced cytotoxicity. Cell Signal. 2015;27(7):1533-1543. doi:10.1016/j.cellsig.2015.04.001
54. Ho TK, Shiwen X, Abraham D, Tsui J, Baker D. Stromal cell-derived factor-1 (SDF-1)/CXCL12 as potential target of therapeutic angiogenesis in critical leg ischaemia. Cardiol Res Pract. 2012;2012:143209. doi:10. 1155/2012/143209
55. Petit I, Jin D, Rafii S. The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol. 2007;28(7):299-307. doi:10.1016/j.it.2007.05.007
56. Yoshida T, Delafontaine P. Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy. Cells. 2020;9(9):1970. doi:10. 3390/cells9091970
57. Wang J, Zhu Q, Cao D, et al. Bone marrow-derived IGF-1 orchestrates maintenance and regeneration of the adult skeleton. Proc Natl Acad Sci U S A. 2023;120(1):e2203779120. doi:10.1073/pnas.2203779120
58. Baghy K, Szakadáti H, Kovalszky I. Decorin the antifibrotic proteoglycan and its progression in therapy. Am J Physiol Cell Physiol. 2025;328(6): C1853-C1865.
59. Dong Y, Zhong J, Dong L. The role of decorin in autoimmune and inflammatory diseases. J Immunol Res. 2022;2022:1283383. doi:10.1155/ 2022/1283383
60. Bansal P, Kajal, Sharma S, Mazumder A. Role of BMP-7 in cardiovascular diseases: from molecular mechanisms to therapeutic horizons. Curr Drug Targets. 2025. In press.
61. Smith C, du Toit R, Ollewagen T. Potential of bone morphogenetic protein-7 in treatment of lupus nephritis: addressing the hurdles to implementation. Inflammopharmacology. 2023;31(5):2161-2172. doi:10. 1007/s10787-023-01279-0
62. Aoi W, Hirano N, Lassiter DG, et al. Secreted protein acidic and rich in cysteine (SPARC) improves glucose tolerance via AMP-activated protein kinase activation. FASEB J. 2019;33(9):10551-10562. doi:10.1096/fj.201900822R
63. Park SY, Hwang BO, Song NY. The role of myokines in cancer: crosstalk between skeletal muscle and tumor. BMB Rep. 2023;56(7):365-373. doi: 10.5483/BMBRep.2023-0099